Join the Avastin group to help and get support from people like you.
Avastin News (Page 2)
FDA Approves Avastin (bevacizumab) Plus Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer
South San Francisco, Calif. – November 14, 2014 – Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Avastin in combination with...
FDA Approves Avastin for Metastatic Cervical Cancer
August 14, 2014 – The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to treat patients with persistent, recurrent or late-stage (metastatic) cervical cancer. ...
FDA Medwatch Alert: Avella Specialty Pharmacy Sterile Medications: Recall - Concerns Of Sterility Assurance At Testing Vendor
ISSUE: Avella Specialty Pharmacy is voluntarily recalling two compounded sterile medications, Bevacizumab 1.25 mg/0.05 mL PF and Vancomycin PF (BSS) 1%. The recall is a result of concerns of...
FDA Medwatch Alert: Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
ISSUE: Clinical Specialties is voluntarily recalling Avastin unit dose syringes. The product has or potentially could result in an infection within the eye. Clinical Specialties has received reports...
FDA Medwatch Alert: Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient
ISSUE: FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab),an injectable cancer medication, found in the U.S. contains no active ingredient. Even if t...
FDA Medwatch Alert: Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices
ISSUE: The FDA is warning healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United...
FDA Medwatch Alert: Avastin (bevacizumab) - Jul 14, 2008
[Posted 07/14/2008] Genentech, Inc. informed healthcare professionals of reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin in...
FDA Medwatch Alert: Avastin (bevacizumab) - Apr 21, 2007
[Posted 04/21/2007] Genentech and FDA notified healthcare professionals of important new safety information regarding tracheoesophageal (TE) fistula formation in a recent clinical study in patients...
FDA Medwatch Alert: Avastin (bevacizumab) - Sep 25, 2006
[Posted 09/25/2006] Genentech and FDA notified healthcare professionals about revisions to the WARNINGS and ADVERSE REACTIONS sections of the prescribing information to inform healthcare...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Colorectal Cancer, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Renal Cell Carcinoma